| Financial Year |
March 31 2023 |
| Monetary Funds |
682,467,727.16 |
| Held-for-trading Financial Assets |
46,240,131.75 |
| Notes Receivable |
-- |
| Accounts Receivable |
58,807,346.85 |
| Advances to Suppliers |
9,405,850.25 |
| Other Receivables |
23,877,800.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
256,300,284.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
58,094,472.31 |
| Total Current Assets |
1,135,193,612.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
20,619,661.72 |
| Fixed Assetes |
704,536,692.99 |
| Under-construction Projects |
112,228,395.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
150,897,451.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,852,805.77 |
| Deferred Income Tax Assets |
20,844,555.94 |
| Other Non-Current Assets |
3,228,534.87 |
| Sub-Total of Non-Current Assets |
1,705,048,906.20 |
| Total Assets |
2,840,242,519.09 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
269,123,024.04 |
| Accounts Received In Advance |
12,919,340.69 |
| Employee Compensation Payable |
40,804,178.46 |
| Taxes Payable |
20,353,437.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
112,660,854.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
49,243,928.48 |
| Other Current Liabilities |
40,122,233.38 |
| Sub-Total of Current Liabilities |
967,461,619.93 |
| Long-term Loans |
40,054,666.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
740,935,940.94 |
| Total Liabilities |
1,708,397,560.87 |
| Paid-In Capital(Or Share Stock) |
495,580,000.00 |
| Capital Surplus |
325,758,399.78 |
| Surplus Reserve |
21,896,958.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
287,296,223.52 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,131,844,958.22 |
| Owner's Equity（Stockholder's Equity） |
1,131,844,958.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,840,242,519.09 |
